琥珀酸拉米丹结构式
|
常用名 | 琥珀酸拉米丹 | 英文名 | Lasmiditan hemisuccinate |
---|---|---|---|---|
CAS号 | 439239-92-6 | 分子量 | 872.80900 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C42H42F6N6O8 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
琥珀酸拉米丹用途Lasmiditan, also known as COL-144 and LY573144, is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist (K1=2.21 μM) without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study. Lasmiditan showed efficacy in its primary endpoint, with a 2-hour placebo-subtracted headache response of 28.8%, though with frequent reports of dizziness, paresthesias, and vertigo. |
中文名 | 琥珀酸拉米丹 |
---|---|
英文名 | butanedioic acid,2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)pyridin-2-yl]benzamide |
英文别名 | 更多 |
分子式 | C42H42F6N6O8 |
---|---|
分子量 | 872.80900 |
精确质量 | 872.29700 |
PSA | 206.18000 |
LogP | 7.13100 |
储存条件 | -20°C, 密封, 干燥 |
Lasmiditan succinate (USAN) |
2,4,6-Trifluoro-N-(6-((1-methylpiperidine-4-yl)carbonyl)pyridin-2-yl)benzamide hemisuccinate |
UNII-W64YBJ346B |
Lasmiditan succinate |
Lasmiditan hemisuccinate |